Vaccinia immune globulin iv (monograph) Pregnancy Warnings
Vaccinia immune globulin (VIGIV) has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. VIGIV is only recommended for use during pregnancy when clearly needed.
See references
